Bill exempts user fees.
A bipartisan duo of House members has reintroduced the Food and Drug Administration Safety Over Sequestration Act, or FDA SOS Act, which exempts FDA user fees from sequestration. FDA user fees are 100% industry-financed and are used specifically for the approval of safe and effective drugs and devices. In the event of another sequester like the budget sequestration of 2013, the FDA could lose tens of millions of dollars, preventing it from meeting its congressionally mandated responsibilities and leaving patients without lifesaving therapies. The authors of the bill, Reps. Anna Eshoo (D., Calif.) and Leonard Lance (R., N.J.), have concerns that a repeat of the 2013 sequester could reduce not only the FDA's budget from Congress, but also reduce industry-financed user fees to the agency.